You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 13, October 7, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  JAMA Patient Page
 This Article
 •PDF
 •Spanish PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Pulmonary Diseases
 •Pulmonary Diseases, Other
 •JAMA Patient Page
 •Cardiovascular Disease/ Myocardial Infarction
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pulmonary Hypertension

The pulmonary artery is the main vessel that carries blood from the heart to the lungs. For a person at rest, blood pressure in a normal pulmonary artery is about 15 millimeters of mercury (mm Hg). In an individual with pulmonary hypertension, the average pressure in the pulmonary artery can be more than 25 mm Hg. This increase in pulmonary artery pressure occurs when the small arteries of the lungs become abnormally narrow. This condition can eventually lead to heart failure and death. Pulmonary hypertension can be idiopathic (unknown cause), familial (runs in families and is often linked to a genetic cause), or associated with other medical conditions. The October 7, 2009, issue of JAMA includes an article about the effects of iron supplementation on pulmonary hypertension due to low oxygen levels at high altitudes. This Patient Page is based on one published in the January 23, 2008, issue of JAMA.


Figure 1

CONDITIONS ASSOCIATED WITH PULMONARY HYPERTENSION

  • Low oxygen levels due to high altitude or heart or lung disorders
  • Connective tissue diseases (autoimmune diseases such as scleroderma, sarcoidosis, or lupus)
  • Portal hypertension (resulting from liver disease)
  • HIV infection
  • Drugs and toxins (appetite suppressants, cocaine, amphetamines)
  • Thyroid disorders
  • Myeloproliferative disorders (overproduction of red or white blood cells)
  • Hemoglobinopathies (abnormal oxygen-carrying proteins in red blood cells, such as found in sickle cell anemia)
  • Blood clots in pulmonary arteries


SYMPTOMS OF PULMONARY HYPERTENSION

Initial symptoms may be minor and diagnosis may be delayed for several years until symptoms worsen. Typical symptoms may include

  • Shortness of breath following exertion
  • Excessive fatigue
  • Dizziness and fainting
  • Ankle swelling
  • Bluish lips and skin
  • Chest pain


DIAGNOSIS OF PULMONARY HYPERTENSION

There is not one specific way to diagnose pulmonary hypertension. A doctor usually runs a series of tests to measure blood pressure in the pulmonary arteries, determine how well the heart and lungs are working, and rule out other diseases.


FOR MORE INFORMATION


INFORM YOURSELF

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A previous Patient Page on the evaluation of lung function was published in the May 16, 2007, issue.

Sources: American Lung Association; National Heart, Lung, and Blood Institute; Pulmonary Hypertension Association

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

TOPIC: LUNG DISEASE

John L. Zeller, MD, PhD, Writer; Alison E. Burke, MA, Illustrator; Richard M. Glass, MD, Editor

JAMA. 2009;302(13):1490.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension: Two Randomized Controlled Trials
Thomas G. Smith, Nick P. Talbot, Catherine Privat, Maria Rivera-Ch, Annabel H. Nickol, Peter J. Ratcliffe, Keith L. Dorrington, Fabiola León-Velarde, and Peter A. Robbins
JAMA. 2009;302(13):1444-1450.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.